Germline testing in urothelial cancer: A narrative review of evidence, guidelines, and testing frameworks

Urothelial cancer is a type of cancer that begins in the urothelial cells lining the inside of the bladder, ureters, or renal pelvis of the kidney. I

Highlights
  • •Germline P/LP variants occur in 10% to 15% of urothelial cancers, up to 20% in UTUC.
  • •Lynch syndrome is the leading hereditary cause; MSH2 confers the highest risk.
  • •MMR-deficient tumours, seen in Lynch, are highly sensitive to immune checkpoint inhibition.
  • •Tumour MMR screening is imperfect and limited by scarce tissue in UTUC biopsies.
  • •Universal germline testing in UTUC and a bladder cancer framework are overdue.

https://www.sciencedirect.com/science/article/abs/pii/S1078143926005971

Leave a comment